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1. Introduction 
Neuropathic pain syndromes are, in the majority of cases, chronic conditions related to 
injuries or diseases occurring at different levels in the nervous systems which are involved 
in signaling pain. (Treede et al., 2008) 
Regarded as heterogeneous states, usually these conditions could not be explained by a 
single cause or a single specific lesion. Many of these syndromes are expressed by the same 
clinical symptoms in different etiologies (e.g touch-evocated pain exists in both post herpetic 
neuralgia and painful diabetic neuropathy) and could be based on the same mechanism. 
However in the same disease, one mechanism may produce painful symptoms that take 
different aspects. (Gilron et al., 2006) 
As neuroplastic changes occur in different structures of the nervous system, the distribution 
of pain will no longer respect nerves, roots, segments, proximal or distal territories. 
(Finnerup et al., 2006) 
Recent advances in the field of pain mechanisms produced increasing evidences that old 
classifications based on underlying disease or anatomic grounds (see table 1) provide insufficient, 
arguments for the therapeutic approach. (Dworkin et al., 2003; Baron, 2006; Baron et al.. 2010).  
Therefore, we discuss in this chapter whether a different strategy, in which pain is analyzed 
on the basis of underlying mechanism, could provide an alternative approach for diagnosis 
of patients suffering from neuropathic pain conditions with the aim of obtaining a better 
treatment outcome. 
Quantitative sensory testing applied on 1236 patients suffering from different neuropatic 
pain conditions revealed that despite the heterogeneity in etiology and anatomical 
distribution, neuropathic pain is characterized by certain clinical features (Maier et al., 2010): 
- widespread pain otherwise unexplainable; 
- burning continuous spontaneous pain; 
- sudden, unprovoked attacks of pain; 
- evoked pain (stimulus dependent); 
- pain located in a neuroanatomical area with partial or complete sensory deficit; 
- aftersensations; 
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- abnormal summation of pain; 
- sympathetic involvement.  
 
Peripheral 
neuropathic pain 
syndromes 
Focal and multifocal 
neuropathies 
Phantom pain, nerve partial or complete 
transection pain, neuroma, entrapment 
syndromes, postherpetic neuralgia, diabetic 
mononeuropathy, ischemic neuropathy, 
plexopathies (radiation, diabetic, infiltrative, 
idiopathic, hereditary), trigeminal or 
glossopharyngeal neuralgia, vascular 
compression
Generalized 
neuropathies 
(polyneuropathies) 
Metabolic or nutritional
Diabetes, amyloidosis, hypothyroidism, beri 
beri, pellagra 
Drug-related 
Antiretrovirals, cisplatin, oxaliplatin, 
thalidomide, vincristine, methylthiouracil, 
disulfiram, ethambutol, isoniazid, 
nitrofurantoin, chloramfenicol, metronidazol, 
taxoids, gold 
Toxin-related 
Thallium, arsenic, acrylamide, ethylene oxide, 
dinitrophenol, penthachlorofenol 
Hereditary 
Amyloid neuropathy, Fabry’s disease, 
hereditary sensory and autonomic neuropathy 
type 1 
Paraneoplastic syndromes 
Paraneoplastic peripheral neuropathy 
Infective or post-infective, immune 
Acute inflammatory polyradiculoneuropathy, 
HIV, borreliosis  
Other 
Idiopathic small-fibers neuropathy, 
erythromelalgia  
Central 
neuropathic pain 
syndromes 
Vascular lesion in the brain (frequently in the brainstem and thalamus) 
and spinal cord 
Inflammatory diseases: multiple sclerosis and other 
Traumatic spinal cord and brain injury 
Tumors 
Abscesses 
Syringomyelia and syringobulbia 
Parkinson disease 
Mixed pain 
syndromes 
Chronic low back pain with radiculopathy
Complex regional pain syndromes 
Cancer pain with malignant plexus invasion
Table 1. Neuropathic pain classification based on anatomy and underlying disease 
(modified from Baron R. et al., 2010) 
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These symptoms may occur in various combinations, but do not necessarily have to be 
present all together. The association of symptoms and signs is compatible with the process 
of general sensitization of the second and third order neurons in the central nervous system. 
These relay structures have lost part of their normal input that has been substituted by an 
altered afferent influx. Commonly, the process of sensitization is considered to be an 
essential phenomenon that explains persistent neuropathic pains. (Baron, 2006; Baron et al., 
2010). 
New insights regarding the pathophysiological mechanisms behind spontaneous and 
evoked phenomena were substantiated by experimental studies in animal models and 
clinical trials. The most relevant for clinical practice are: 
- lesion in a peripheral nerve induce ectopic activity in the primary nociceptive afferent 
fibers both in injured and intact terminals. Alteration of ion-channels and up-regulation 
of a certain receptor proteins in the peripheral nociceptive endings are responsible for 
spontaneous pain as well as for allodynia and hyperalgezia that might evolve in the 
area innervated by the nerves with ectopic activity. (Wu et al. 2002; Amir et al. 2005). 
- the local inflammatory reaction following a certain injury and exposure of the nerve 
terminals to the so called “inflammatory soup” may also lead to molecular changes in 
nociceptive neurons that will became abnormally sensitive, developing spontaneous 
pathological activity that contribute to peripheral sensitisation. This process is 
correlated with spontaneous and evoked pain and could occur even without any 
underlying nerve damage. (Finnerup et al. 2006) 
- hyperactivity in the nociceptors lead to secondary changes in neurons processing 
somatosensory information in the dorsal horn, spinal cord and brain. Hence the input 
from the mechanoreceptive A beta, A delta fibers might activate second order neurons 
and hence, non innocuous stimulation could became painful. This process is called 
central sensitization and could be responsible for the central pain syndromes as 
well.(Baron , 2006; Finnerup et al. 2006). 
- loss of inhibitory interneurons in the dorsal horn and brain stem in the context of 
neuroplastic changes may lead to alteration in segmental and descending modulation. 
Synaptic activity changes in the dorsal horn of the spinal cord thereby results in 
hyperexcitability of the second order neurons due to alteration of inhibitory control. 
This mechanism may mediate mechanical and thermal hyperalgezia. (Moore et al. 2002; 
Scholz et al. 2005).  
- hyperactivity at the level of sensitized nociceptors that favor pain persistence and 
allodynia are correlated with increasing activity in the sympathetic nervous system. 
Spontaneous pain and dynamic mechanical hyperalgesia might get enhanced by the 
secondary changes in the sympathetic activity. This process could be interfered by 
sympathetic blocks. (Zhuo et al. 2011) 
- activation of the glial cells in the dorsal horn, in the context of neuropathic pain 
conditions, is demonstrated to be responsible for neuronal hyperexcitability. Thus 
microglial cells are activated during the initial stages as well as the astrocites are more 
involved in the process of pain maintenance. (Boucsein et al.2000; Ji et al 2007; Gosselin 
et al. 2010) 
- cortical maps reorganization and the role of mirror neurons in the brain have been 
proposed in the generation of phantom limb pain. (Subedi et al. 2011) 
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2. Diagnosis 
The neuropathic pain represents a devastating condition that can be diagnosed by taking a 
relevant history of pain and by adequately performed neurological examination. 
Complementary studies, including blood and serologic tests, electrophysiological studies, 
imaging procedures will contribute with information about the etiology of the underlying 
disease and also to predict the outcome. (Gilron et al.2006; Haanpaa et al 2011).  
Although the neuropathic pain is seen as a chronic condition, there are situations, poorly 
recognized, of acute neuropathic pain. Despite the fact that acute pain is perceived as having 
a nociceptive nature, in a small percent of cases, the pain is mixed, including a neuropathic 
component as well (e.g. acute disc herniation, postsurgery pain). Even if the incidence of 
acute neuropathic pain in acute pain services is low (1-3%), its importance resides in the 
high risk to progress to a persistent and debilitating status. Time interval which defines 
acute neuropathic pain is 6-12 weeks. (Hayes et al., 2002; Gray, 2008) 
The nociceptive, neuropathic and mixed pains are the three main types of pain. The first one 
is induced by injured tissue, the second one is caused by a disorder in the somatosensory 
system and the third one refers to coexistence of the first two. To diagnose neuropathic pain 
and to differentiate it from the nociceptive type, or to identify the nociceptive component of 
the mixed condition, it is mandatory to analyze in detail the type of somatosensory 
abnormalities in a given case. By contrast with other neurological symptoms and signs (e.g 
motor deficit) pain as a subjective sensory symptom is difficult to measure because it is not 
something visible and does not involve only physical aspects, but also psychological and 
emotional components. (Baron et al 2010) 
2.1 Interview and questionnaires 
The first step in pain diagnostic and evaluation is a very detailed history with: 
- description of qualities of pain; 
- duration of pain;  
- time course pattern; 
- rating intensity of pain; 
- the context and type of onset; 
- presence of relieving factors; 
- existence of provocative or enhancer factors; 
- topographic distribution of pain; 
- coexistence of other positive symptoms such as paresthesia; 
- impact on daily activities and sleep.  
Standardized screening tools have been developed to distinguish neuropathic pain on the 
basis of patient reported verbal descriptors of pain during the interview and a limited 
bedside examination. The purpose of these questionnaires is to identify the patients with 
neuropathic pain and also to distinguish between different pathophysiological groups. 
Some of these screening tools include items that refer to rating scales, time course pattern 
and topographical distribution. This particular aspect may help the examiner to find out if 
pain distribution respects a nerve or root territory. Moreover, the rating scales are also 
useful to monitor the efficacy of different therapeutic interventions (Cruccu  et al., 2004; 
Haanpaa et al, 2011). 
www.intechopen.com
 
Overview of Neuropathic Pain Diagnosis and Assessment – An Approach Based on Mechanisms 
 
5 
LANSS (Leedes Assessment of Neuropathic Symptoms and Signs Scale) is the first tool 
developed more for the diagnosis of neuropathic pain than for its rating(9) and consists of 
five items for description of symptoms and two items for clinical examination. Although it 
was not designed for measurement, LANNS proved its sensitivity to treatment. This tool 
has been subsequently tested and validated in several settings with sensitivity and 
specificity ranging from 82% to 91% and 80% to 94% respectively, comparing with clinical 
diagnosis. There is also a version of a self-report questionnaire, S-LANNS (Bennett, 2001). 
NPQ (Neuropathic Pain Questionnaire) consists of twelve items of which ten refer to 
sensations and sensory responses and two are related to affect. NPQ has showed a 
sensitivity of 66% and a specificity of 74% versus clinical diagnosis. There is, also, a short 
variant that has only 3 items for similar discriminative properties (tingling, numbness and 
increasing pain in response to touch) (Krause et al., 2003). 
DN4 (Douleur Neuropathique en 4 questions) is a questionnaire initially developed and 
validated in French and consists of seven items related to symptoms, which can be used as a 
self-report, and three items related to clinical examination. This tool is easy to use and a total 
score of 4 out of 10 or more suggests neuropathic pain. The DN4 proved 83% sensitivity and 
90% specificity when compared with clinical diagnosis (Bouhassira et al., 2005). 
ID-Pain does not require a clinical examination and was designed rather to screen for the 
presence of a neuropathic component. It consists of five sensory descriptor items with one 
item asking whether the pain is located in the joints (to identify nociceptive pain). In the 
validation study, 22% of patients in the nociceptive group, 39% in the mixed group and 58% 
in the neuropathic pain group scored above 3 points, the recommended cut-off score. 
(Portenoy, 2006). 
PainDetect was developed and validated in a multicenter study conducted in Germany and 
includes seven weighted sensory descriptor items (from never to very strongly), two items 
relating to spatial (radiating and topography) and temporal characteristics of individual 
pain pattern and does not require clinical examination. This questionnaire showed a 
sensitivity of 85% and a specificity of 80% (Freynhagen et al., 2006). 
Neuropathic Pain Scale (NPS) was designed and only preliminary validated in 1997 for 
evaluation of neuropathic pain symptoms (18). Although NPS has proved some sensitivity 
to treatment, it is no clear whether is adapted to detect differential effects of treatment on 
neuropathic symptoms. It consists in twelve items, self-reported, about the intensity and 
quality of pain (Galer et al., 1997). 
Neuropathic Pain Symptoms Inventory (NPSI) includes ten descriptors and two items about 
temporal pattern of pain, that allow to differentiate and quantify five distinct features, 
clinically relevant, and sensitive to treatment. The questionnaire could be used to identify 
subgroups of patients with neuropathic pain characterized by specific clusters of symptoms 
and to verify if they respond in a different way to various pharmacological agents. The most 
important feature of this tool is the sensitivity to treatment variables (Bouhassira et al., 2004). 
Standardized Evaluation of Pain (StEP) combines sixteen questions in the interview and 
twenty-three standardized clinical tests to evaluate symptoms and signs related to pain 
and to differentiate between various pain phenotypes reflecting distinct mechanisms. 
Scholz and colleagues evaluated the diagnostic utility of StEP in patients with low back  
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Symptoms Definition Bedside exam Expected 
pathological 
response 
Mechanism(s) 
Spontaneous sensations or pain 
Paresthesia Non-painful 
abnormal 
sensation 
Grade 
intensity(0-10) 
- Spontaneous 
activity in low 
threshold A-ǃ 
afferent 
Dysesthesia Unpleasant but 
non-painful 
abnormal 
sensation 
Grade 
intensity(0-10) 
- Spontaneous 
activity in C/A-δ 
afferents 
Paroxysmal pain Attacks for 
seconds of 
shooting, 
stabbing or 
electric shock-
like 
Number, 
Grade(0-10) 
- Spontaneous 
activity in C-
nociceptors 
 
Superficial 
burning pain 
Permanent pain 
located in the 
skin often of 
burning quality
Grade(0-10) - Spontaneous 
activity in C-
nociceptors? 
Deep pain Permanent pain 
located in the 
muscles, bones, 
or internal 
organs 
Grade(0-10) - Spontaneous 
activity in 
joint/muscle 
nociceptors? 
Sympathetic 
maintained pain 
Sustained 
burning pain 
associated with 
vasomotor, 
sudomotor and 
trophic changes 
on skin 
 
Grade(0-10) - Peripheral 
sensitization: 
sympathetic-
afferent coupling 
Evoked pain 
Dynamic 
allodynia 
provoked by 
mechanical 
stimulation 
Pain provoked 
by normally 
non-painful 
light-pressure 
moving stimuli 
on skin 
Stroking skin 
with painter’s 
brush, cotton 
swab or gauze 
 
Grade(0-10) 
Sharp burning 
superficial pain in 
the primary 
affected zone, 
spreading into 
unaffected skin 
areas(secondary 
zone) 
Central 
sensitization: 
A-ǃ fibers input 
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Mechanical static 
hyperalgesia 
Pain provoked 
by normally 
non-painful 
gentle static 
pressure stimuli 
on skin
Apply gentle 
mechanical 
pressure to skin
 
Grade(0-10) 
Dull pain 
presented in the 
area of affected 
primary afferent 
nerve endings 
(primary zone)
Peripheral 
sensitization 
Mechanical 
punctuate or pin-
prick 
hyperalgesia 
Pain provoked 
by normally 
stinging but 
non-painful 
stimuli 
Prick skin with 
a safety pin, 
sharp stick or 
stiff von Frey 
hair 
 
Grade(0-10) 
Sharp superficial 
pain presented in 
the primary 
affected zone, but 
spreads beyond 
into unaffected 
skin areas 
(secondary zone) 
Central 
sensitization: A-δ 
fibers input 
Temporal 
summation 
Increasing pain 
sensation 
(wind-up-like 
pain) from 
repetitive 
application of 
identical single 
noxious stimuli
Prick skin with 
safety pin at 
intervals of 3 s 
for 30 s 
 
Grade(0-10) 
Sharp superficial 
pain of increasing 
intensity 
Central 
sensitization: A-δ 
fibers input 
Aftersensation Pain occurred 
during the 
stimulation and 
persists more 
then seconds 
after stimulus 
cessation 
Grade(0-10)
Duration 
Persistent evoked 
pain 
Central 
sensitization 
Cold hyperalgesia Pain provoked 
by non-painful 
cold stimuli 
Contact skin 
with objects of 
20° C for 10 s 
 
Grade(0-10) 
Painful burning 
temperature 
sensation 
presented in the 
area of affected 
primary afferent 
nerve endings 
(primary zone) 
Peripheral 
sensitization with 
reduced 
activation 
threshold to cold 
Heat hyperalgesia Pain provoked 
by non-painful 
heat stimuli 
Contact skin 
with objects of 
40° C for 10 s 
 
Grade(0-10) 
Painful burning 
temperature 
sensation 
presented in the 
area of affected 
primary afferent 
nerve endings 
(primary zone)
Peripheral 
sensitization with 
reduced 
activation 
threshold to heat 
Table 2. Definitions and assessment of sensory symptoms in patients with neuropathic pain 
(modified from Baron et al., 2010) 
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pain. The StEP identified the radicular pain with 92 % sensitivity and a specificity of 97% 
(Scholz et al., 2009).  
One of the most important aspects in the patient’s interview is whether the pain is 
spontaneous or stimulus depended. 
The spontaneous pain can be continuous or paroxysmal. In case of continuous neuropathic 
pain, the most common verbal descriptor used by patients to describe its quality is 
“burning”. There are also other words the patients have used to describe their pain as a cold 
(frozen) sensation, stinging, electric shock, painful pins and needles, dull, squeezing, 
shooting, stabbing, cramping, throbbing, sharp, or pulling. Episodic or paroxysmal type of 
pain is usually lasting for seconds and is described as a shooting, electric, shock-like or 
stabbing sensation. 
A thorough interview can reveal different types of evoked pain (hyperalgesia, allodynia). 
Thus painful symptoms could be provoked by light touch, mild pressure, heat or cold and 
also might be associated with the presence of an aftersensation phenomena. Hyperalgesia 
(an increased response to noxious stimuli by lowering the pain threshold) and allodynia 
(pain due to non-noxious stimulus) are typical elements of neuropathic pain.  
The stimulus-evoked pain is further classified according to the stimulus type (mechanical, 
thermal, and chemical) and the dynamic or static nature of stimuli that provoke it. Usually 
the evoked pain stops after cessation of the stimulation, but sometimes it can persist for 
minutes, hours or even days, causing aftersensations. This aspect is mainly explained by 
involvement of a central sensitization process.  
Paresthesia (an abnormal, non-painful sensation) and disesthesia (an abnormal, unpleasant 
and non-painful sensation) whether spontaneous or evoked, may coexist with pain. They 
can be described as crawling, numbness, itching and tingling sensations and reflect 
peripheral nociceptor hyperexcitability with spontaneous activity in low-threshold A-ǃ 
afferents and respectively in C/A-δ afferents. (see table 2) (Baron et al., 2010). 
Usually the screening tools provide immediate information and some of them can be fully 
applied to the patient without any prior physical examination, for example in the waiting 
room. Many of them are suitable to be used by the non-specialist physician in order to 
identify potential patients with neuropathic pain. However, these screening tools may miss 
10-20% of patients with clinical diagnosed neuropathic pain. (Benett et al., 2007). There are 
many screening tools designed for the diagnosis and assessment of neuropathic pain and 
none of them cover the entire spectrum of symptoms and signs that might be encountered in 
this condition. It is possible, therefore, to use a combination of these questionnaires (see 
table 3) to get a good picture of neuropathic pain condition for an individual patient. 
(Cruccu et al., 2009) 
2.2 Assessment of comorbidities  
Comorbidities  are recognized as a major factor that impact the outcome of neuropathic pain 
conditions. The most common spectrum of associated disorders includes poor quality of 
sleep, depression and anxiety. 
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Symptoms/Questionnaire LANSS NPQ DN4 ID-Pain painDetect NPSI StEP 
 
Self reporting symptoms         
Ongoing pain rating         
Electric shocks or shooting        
Hot or burning        
Painful cold or freezing pain        
Pricking, tingling pins, 
needles(any dysesthesia) 
        
Numbness        
Itching        
Pain provoked by light 
touching 
       
Pain provoked by mild 
pressure 
       
Pain provoked by heat or 
cold 
       
Pain provoked by changes 
in weather 
       
Pain provoked by activity or 
body position 
       
Temporal patterns         
Pain limited to joints        
Location, superficial or deep        
Topography        
Radiation of pain        
Autonomic changes        
Affect disturbances        
Physical examination 
Abnormal response to cold 
temperature (decrease or 
allodynia) 
       
Hyperalgesia        
Abnormal response to blunt 
pressure (decreased or 
evoked pain) 
       
Decreased response to 
vibration 
       
Brush allodynia        
Raised soft touch threshold        
Raised pinprick threshold        
Straight-leg-raising test        
Skin changes        
Table 3. Screening tools-items inventory (modified from Bennett M.I. et al., 2007) 
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Patients who suffer from chronic pain experience difficulties in initiating and maintaining 
sleep. Sleep deprivation has been associated with a decreased pain threshold. The 
interrelationship of these factors is complex. Many chronic pain patients are depressed and 
anxious; sleep deprivation can lead to anxiety; and depression can be both the cause and the 
result of sleep disturbances. Therefore, sleep as well as mood should be evaluated in 
patients suffering from painful conditions. Several specific instruments  are used in practice 
to elicit qualitative and quantitative information from chronic pain patients.  
PHQ-9 and MOS sleep questionnaire were used to track co-morbidities in a study that 
assessed the PainDETECT questionnaire as a screening tool to predict the likelihood of a 
neuropathic pain component in chronic pain disorders (Lowe et al., 2004; Hays & Stewart, 
1992). 
The study revealed fundamental differences, in respect of perceived pain and of various co-
morbidities, between low back pain patients with neuropathic and those with nociceptive 
components and provided important information on the association between neuropathic 
pain  and the occurrence and severity of co-morbidities. Patients with neuropathic pain 
generally experience a more severe burden of co-morbid disorders than patients affected 
only by nociceptive type of pain (Freynhagen et al., 2006). 
2.3 Neurological examination 
An injury anywhere in the somatosensory system typically, leads to an area of sensory 
deficit distributed in the related innervations territory. These negative sensory signs may be 
expressed as a deficit in the mechanical or vibratory perception, which indicates damage of 
the large diameter afferent fibers or of the dorsal column tract. The picture could include 
also a deficit of noxious and thermal perception, which indicates damage of the small 
diameter afferent fibers or of the central pain processing pathways such as the 
spinothalamic tract. 
A standardized bedside examination of patients with neuropathic pain must include the 
following components: touch, pressure, vibration, pinprick, cold, heat, temporal summation. 
The responses should be graded as normal, decreased or increased. When present, allodynia 
and hyperalgesia should be quantified by measuring the intensity and the area that is 
affected. It is generally agreed that assessment should be carried out in the area of 
maximum pain with the controlateral or neighboring reference area, free of pain, as a 
control if possible. Touch can be assessed by gently applying cotton swab or von Frey 
filaments of 2 g and 26 g strength to the skin, pin-prick sensation by the response to sharp 
pinprick stimuli, cold and heat sensation by measuring the response to thermal stimuli (e.g. 
metal objects kept at 20° C or 40° C), vibration sensation by the response to a tuning fork. 
(Arning & Baron, 2009) 
Mechanical dynamic allodynia and mechanical static hyperalgesia can be evaluated using a 
painter’s brush and respectively a blunt eraser end of a pencil. Abnormal temporal 
summation consists to increasing pain sensation (wind-up-like pain) from repetitive 
application of identical single noxious stimulus (mechanical or thermal) and is the clinical 
equivalent of increasing neuronal activity after repetitive noxious C-fiber stimulation of 
more than 3 Hz. The antagonists of NMDA receptors can block this process.  
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Inspection of the skin within the painful area is also an important gesture to note the 
presence of vasomotor, sweating and trophic changes which define sympathetic maintained 
pain and express a pathological adrenergic coupling between sympathetic postganglionic 
fibers and nociceptive afferent fibers.  
In the chronic conditions, trophic changes of the skin and nails occur as do motor symptoms 
such as weakness, tremor and dystonia (Cruccu et al. 2004, Cruccu et al.,2009). 
Nerve percussion at points of entrapment, compression or irritation can elicit electrical 
sensations, pins and needles in innervation’s territory (Tinel’s sign). 
As in the case of spontaneous pain assessment, it is important to establish topographical 
distribution of evoked pains because as the neuroplastic changes develop, the pain 
distribution will no longer respect nerves, roots, segmental, cortical territory. Hence, 
primary hyperalgesia or allodynia represent pain provoked by stimuli applied within a 
nerve/root territory with ectopic activity. Secondary hyperalgesia or allodynia represents 
pain occurred by application of stimuli in the neighboring area of innervations territory of 
the injured nerve/root. 
Neurological assessment of neuropathic pain also should include an examination of the 
autonomic nervous system and a detailed inventory of the somatomotor involvement to 
define the underlying disease and the extension of it. The distribution of the motor deficit 
could help us sometimes to differentiate between primary and secondary 
hyperalgesia/allodynia and to localize the injury. 
As peripheral and central sensitization develop, in attempt to control pain, the harmful 
condition is most of the times no longer important because the neuropathic pain persists 
long after the cessation of the initial injury. However, the management of the ongoing 
underlying diseases (eg metabolic disorders) remains important rather to prevent 
appearance of new lesions of somatosensory nervous system than to control neuropathic 
pain (Baron et al., 2010). 
However, the non-sensory neurologic symptoms and signs can independently contribute to 
pain and disability. In the case of associated weakness, patients are more prone to adopt 
vicious positions and therefore, mixed pain could develop by superimposing the nociceptive 
component related to joints or tendon structures (Dworkin et al. 2003).  
2.4 Ancillary tests 
When pain is the only manifestation of an injury in the somatosensory system, additional 
diagnostic information could come from the use of ancillary tests (see table 4). 
Some aspects must be considered an attempt to use complementary tests to support the 
diagnosis and characterize the involvement of specific neuropathic pain mechanisms 
(Horowitz et al, 2007): 
-  using these laboratory tests, the presence, distribution and mechanisms of neuropathic 
pain only can be inferred because the available tests evaluate nervous system structures 
and functions presumed to be relevant to pain perception and transmission; 
-  since pain mediating fibers (small myelinated, Aδ, and unmyelinated, C fibers) are also 
responsible for other measurable functions, (e.g. temperature perception and autonomic 
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activity), many  tests have focused on proving alterations in these modalities in order to 
verify A-δ or C-fiber damage; 
- in the clinical expression of each particular disorder is a spectrum of symptoms and 
signs that reflect neural injury, with chronic pain occurring in only a small percentage 
of affected individuals. 
 
Fibers  Sensation Testing 
  Clinical Laboratory 
  Bedside 
assessment 
Expected 
pathological 
response 
QST Other 
A-ǃ Touch  Piece of painter’s 
brush or cotton 
swab 
Reduced 
perception 
(hypoesthesia) 
Von Frey filaments NCS, SEPs 
Vibration  Tuning fork  
(128 Hz) 
Reduced 
perception of 
threshold 
(pall-hypoesthesia)
Vibrameter NCS, SEPs 
A-δ Pinprick, 
sharp pain
Prick skin with a 
pin single stimulus
Reduced perception 
(hypoalgesia) 
Weighted needles LEPs, 
IENF 
Cold  Thermoroller  
(20° C) 
Reduced 
perception 
(thermal 
hypoesthesia) 
Thermode  None  
C Warmth  Thermoroller  
(40° C) 
Reduced 
perception 
(thermal 
hypoesthesia) 
Thermode LEPs, 
IENF 
Burning none - Thermode LEPs, 
IENF 
IENF intra-epidermal nerve fibre, LEP laser-evoked potential, NCS nerve conduction study, QST 
quantitative sensory testing: SEP, somatosensory-evoked potential 
Table 4. Summary of assessment methods of nerve sensory functions (modified from Cruccu 
et al., 2004). 
2.4.1 Clinical neurophysiology 
The usual neurophysiologic tests (with surface electrodes for nerve stimulation and evoked 
potential recording) asses activity of the largest and fastest conducting sensory and motor 
myelinated nerve fibers (Aǂǃ). In order to assess the involvement of the central nervous 
system or the proximal part of the peripheral nerves, somatosensory and magnetic evoked 
potential studies can be helpful. 
Although, unfortunately A-and C-fiber activities cannot be tested with these techniques, the 
abnormalities from these tests can be used to corroborate the clinical impression of damage to 
a specific peripheral nerve or to peripheral nerves in general as in a polyneuropathy (level A 
recommendation in the EFNS guidelines for neuropathic pain assessment, Cruccu et al., 2004).  
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2.4.2 Quantitative sensory testing  
Quantitative sensory testing (QST) measures sensory thresholds for pain, touch, vibration 
and hot and cold temperature sensations. With this technology, specific fibers functions can 
be assessed: Aδ-fibers with cold and cold-pain detection thresholds, C-fibers with heat and 
heat-pain detection thresholds and large fiber (Aǂǃ) functions with vibration detection 
thresholds. The abnormal findings exist in both peripheral and central nervous disorder, 
without any distinction (Rolke et al., 2006). 
It must be stressed that QST is a psychophysical test and therefore is highly dependent on 
the patient’s alertness, concentration and motivation (level B recommendation EFNS 
guidelines for neuropathic pain assessment, Cruccu et al., 2004). QST is helpful to quantify 
the effects of treatments on allodynia and hyperalgesia and may reveal a different effect of 
treatments on different pain components (level A recommendation in the EFNS guidelines 
for neuropathic pain assessment, Cruccu et al., 2010).  
2.4.3 Autonomic function testing 
Autonomic evaluation is an important step in refining the neuropathic pain diagnosis based 
on the frequent association between neuropathic pain disorders and signs of autonomic 
dysfunction (dry eyes or mouth, changes in the color of the skin, temperature, sweating 
abnormalities, edema, orthostatic hypotension, etc) as well as the anatomic similarities 
between fibers processing pain and autonomic functions. The most useful tests are 
quantitative sudomotor axon reflex test (QSART), thermoregulatory sweat test, heart rate 
responses to deep breathing, Valsalva ratio, and surface skin temperature (Novak et al., 
2001). The value of autonomic testing in patients with general neuropathic pain disorder, 
painful small-fiber neuropathy with burning feet has been shown in several studies. 
Autonomic abnormalities were seen in more than 90% of patients (Low et al, 2006). 
2.4.4 Skin biopsy 
In the recent years the histological study of unmyelinated nerve fibers in the skin had 
proved its utility by providing reliable diagnostic information when there is little or no 
clinical evidence of neuropathy, such as in a patient complaining of burning feet and to 
distinguish conditions mimicking a neuropathy. Epidermal nerve fiber density and 
morphology, complex ramifications, clustering, and axon swelling can be quantified 
(Devigli et al, 2003; Kennedy, 2004)  
Reduced epidermal innervations density has been used as mandatory criteria for the 
diagnosis of a small fiber neuropathy (level B recommendation in the EFNS guideline of 
neuropathic pain assessment, Cruccu et al., 2004, 2009). 
2.4.5 Laser evoked potential  
Laser evoked potential (LEP) based on radiant-heat pulse stimuli delivered by laser 
stimulators, provide a selective activation of the afferent fibers and the free nerve endings 
(A-δ and C) (Bromm et al. 1984). The cortical networks that generate LEPs are able to detect 
abrupt changes in the sensory input, but are much less qualified to reflect a slow-changing 
state. Thus, LEPs are inappropriate to reflect the slowly emerging, ill-defined and long 
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lasting phenomena that underlie over-reaction symptoms (hyperalgesia and allodynia), 
which are thought to depend on spino-reticulo-thalamic projection system . Late LEPs 
reflect activity of the A-fibers and ultralate LEPs of the unmyelinated nociceptive pathways 
(Garcia-Larrea & Godinho, 2007).  
For the purpose of studying peripheral and central neuropathic pain, LEP are the most 
sensitive tool compared with any other neurophysiologic test. The finding of a LEP 
suppression helps to diagnose neuropathic pain (level A recommendation in the EFNS 
guideline neuropathic pain assessment, Cruccu et al.,  2009).  
2.5 Pathophysiology – From symptoms and signs to mechanism and vice versa 
Our ability to translate pain complaints and sensory signs into specific physiopathologic 
mechanisms which will have implications for appropriate therapy is only in the beginnings 
(Baron et al. 2010). However, all this process of translation is difficult because: 
- one single mechanism can give rise to several different symptoms; the same mechanism 
can be found in various diseases; 
- in one individual patient different mechanisms might be involved; 
- many of these mechanisms are independent on the etiology of a particular disorder;  
- different mechanisms could lead to the same symptom or sign.  
Different treatment regimens are needed for different pain mechanisms, thereby a 
mechanism based treatment approach would result in efficient analgesia. Hence, to progress 
at this point we have to assume that pain mechanisms can be identified by analyzing 
patient’s individual symptoms and signs (see table 5). 
At present, there are some data that could help us to understand the associations between at 
least some symptoms and suggested underlying mechanisms (Jensen & Baron, 2003).  
It is worth to mention that the pain system is not static and the changes occur in a dynamic, 
step-up, from periphery to central and somewhat unpredictable manner whenever the 
system is activated (Baron, 2006). 
A useful, oversimplified approach is to differentiate processes that involve the following 
(Finnerup &Jensen, 2006): 
- increased firing in primary afferent nociceptors (e.g. ectopic discharges as a result of 
abnormal redistribution of sodium channels in damaged peripheral nerve fibers)  
- changes in the central processing of sensory signals (central sensitization) and, 
consequently, normal sensory perception is amplified and sustained;  
- decreased inhibition of neuronal activity in the central structures (e.g due to loss of 
inhibitory neurons)  
2.5.1 Ectopic nerve activity 
Ectopic nerve activity has been involved in many positive phenomena (spontaneous, ongoing 
or paroxysmal pain, primary hyperalgezia/allodynia), characteristic of neuropathic pain: 
- ongoing spontaneous pain and paroxysmal stimulus-independent pain has been correlated 
with ectopic impulse generation within the nociceptive pathways, either within 
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nociceptive afferent fibers (C- and Aδ-fibers), either in the dorsal root ganglion or at the 
level of the second-order nociceptive neuron by increasing expression of voltage-gated 
sodium channels and secondary lowering action potential threshold until ectopic 
activity takes place (Amir et al. 2005; Wu et al., 2002) 
 
Mechanism Symptoms  Targets 
Peripheral nociceptor hyperexcitability  
Ectopic impulses 
generation, oscillations 
in dorsal root ganglion 
Paroxysmal shooting spontaneous 
pain  
Sodium channels 
Peripheral nociceptor sensitization 
Inflammation within 
nerves: cytokine release
Ongoing spontaneous pain Cytokines  
Reduced activation threshold to: 
Heat  Heat allodynia TRPV1 receptor 
Cold Cold allodynia TRPM8 receptor 
Mechanical stimuli Static mechanical allodynia ASCI receptor(?) 
Noradrenaline  Sympathetic maintained pain ǂ receptor 
Central dorsal horn hyperexcitability  
Central sensitization on spinal level 
Ongoing C-input induces increased synaptic transmission 
Amplification of C 
fibers input 
Ongoing spontaneous pain Presynaptic: 
-μ-receptors 
-calcium channels(ǂ2-δ) 
Postsynaptic: 
-NMDA receptors 
-sodium channels 
-NK1 receptors 
Gating of Aǃ- fibers 
input 
Mechanical dynamic allodynia 
Gating of Aδ- fibers 
input 
Mechanical static hyperalgesia   
Reduction intraspinal inhibitory interneurons 
GABA-ergic Ongoing spontaneous pain 
Evoked pain  
GABA-B receptors 
Opiodergic Ongoing spontaneous pain 
Evoked pain  
μ-receptors 
 
Changes in supraspinal descending modulation 
Decreased inhibitory 
control (NA, 5-HT) 
Ongoing spontaneous pain 
Evoked pain   
ǂ2 receptor 
5-HT receptors 
Increased faciliatory 
control  
Ongoing spontaneous pain 
Evoked pain   
 
Table 5. Mechanisms-symptoms correlations (modified from Baron R. et al., 2006) 
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- heat hyperalgezia in addition to ongoing burning pain can have as underlying 
mechanism spontaneous nerve activity induced by changing expression of vanilloid 
receptor (TRPV1, physiologically activated by noxious heat at about 41°C, and 
additional sensitization to heat by intracellular signal transduction (Fischer & Reeh, 
2007). After a nerve lesion TRPV1 is downregulated on injured nerve fibers and 
upregulated on uninjured C-fibers (Caterina & Julius, 2001). 
- abnormal function and expression of TRPM8, a cold sensitive receptor of TRP family, 
triggered by nerve lesion, with secondary ongoing ectopic discharges have been 
recently identified in a patient with painful neuropathy in combination with cold 
allodynia (Serra et al., 2009). 
2.5.2 Central sensitisation 
Central sensitization can manifest in three ways ((Woolf, 1992; Jensen & Baron, 2003): 
- enlargement of the peripheral area where a stimulus will determine neuronal activation 
(secondary hyperalgezia/ allodynia); 
- increased response to suprathreshold input (hyperalgezia, hyperpatia) 
- previously subthreshold input reach threshold and initiate action potential discharge ( 
allodynia, in particular dynamic mechanical allodynia). 
Central sensitization might develop as a consequence of ectopic activity in the primary 
nociceptive afferent fibers without any structural damage within the central nervous system. 
Ongoing discharges of peripheral afferent fibers lead to postsynaptic changes of the second-
order nociceptive neurons, such as phosphorylation of NMDA and AMPA receptors 
(Ultenius et al., 2007) or expression of voltage-gated sodium channels (Lai et al., 2003).These 
changes determine neuronal hyperexcitability that allow the mechanosensitive Aǃ and Aδ 
afferent fibers with low-threshold to activate second-order nociceptive neurons. As a 
consequence, normally innocuous tactile stimuli such as light brushing or pricking the skin 
become painful. This phenomena are called dynamic and punctate mechanical allodynia 
(Hains et al, 2004). 
2.5.3 Decreased inhibition of neuronal activity in the central nervous structures 
After a peripheral nerve lesion there is a loss of inhibitory GABAergic interneurons in the 
spinal horn. Prevention of interneurons cell death attenuates mechanical and thermal 
hyperalgesia, indicating that desinhibition contributes to neuropathic pain (Moore et al., 
2002). There are, also, other inhibitory neurons, such as descending pathways originating in 
the brainstem, which contribute to modulation of pain and any injury of these opioidergic 
and monoaminergic systems lead to pain exacerbation via a disinhibition process. 
Paroxysms are traditionally thought to be generated by ectopic ongoing discharges from 
sodium channels and, therefore, may respond to sodium-channel blockers (Black et al., 2008; 
Siqueira et al., 2009). However, paroxysms can, also, be seen in patients with small fiber 
neuropathy and deafferentation, pointing to a central mechanism and are reported to be 
relieved by tricyclic antidepressants and serotonin-noradrenaline reuptake inhibitors, 
suggesting changes in supraspinal descending modulation with decreasing monoaminergic 
inhibitory control (Jensen & Baron, 2003).  
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2.5.4 Attempts to group patients according to sensory profiles 
The complexity of neuropathic pain pathophysiology and translating process from 
mechanisms to symptoms and signs, suggests that the individual pattern of sensory 
abnormalities most likely closely reflects the underlying pain-generating mechanism (Baron, 
2010). To identify phenotypic subgroups of patients with distinct sensory pattern several 
approaches were used:  
- a standardized psychophysical technique to test both the nociceptive and non-
nociceptive afferent systems (QST- quantitative sensory testing)  was recently proposed 
by the German Network on Neuropathic Pain(DFNS). The DFNS nationwide 
multicentre trial comprised complete sensory profiles of 1236 patients with different 
types of neuropathic pain. The study conclusion was that a certain association of 
symptoms and signs could suggest a particular underlying mechanisms. For example, a 
combination of heat hyperalgesia with mechanical allodynia and mechanical 
hyperalgesia could indicate peripheral ectopic activity at the level of heat sensitive 
nociceptors that triggers a process of central sensitization. On the other hand, in 
patients with complete sensory loss is very unlikely that peripheral mechanisms are 
responsible for maintaining neuropathic pain (Meier et al., 2010). 
- in another study the tool used to identify relevant subgroups of patients with 
postherpetic neuralgia and painful diabetic neuropathy who were characterized by a 
specific symptom profile, was the pain symptom questionnaire. Using a hierarchical 
cluster analysis were determined five distinct subgroups of patients. The sensory 
profiles showed remarkable differences in the expression of the symptoms, all 
subgroups occurring in both diseases but with different frequencies (Baron et al., 2009). 
- In one study the neuropathic symptoms and sings were assessed using a structured 
interview and standardized bedside examination in patients with painful diabetic 
neuropathy, postherpetic neuralgia and radicular back pain as well as in a group of 
patients with non-neuropathic pain. The physical examination was considered more 
important for the distinction of pain subtypes than were the assessment of symptoms 
during the interview (Woolf et al., 1998). 
All these different techniques to identify subgroups of patients show that there are 
phenotypic differences based on certain combinations of sensory abnormalities across the 
different etiologies and neuropathic pain syndromes. These efforts to identify and 
understand the underlying mechanisms involved in neuropathic pain will lead us to a more 
effective and specific mechanism based treatment approach. However, the management of 
neuropathic pain is, also, a matter of timing. The distinction between peripheral and central 
sensitization could be critical in the evolution and appropriate treatment of neuropathic 
pain (Attal et al., 2008; Baron et al., 2010). 
2.6 Neuropathic pain diagnosis in special populations 
2.6.1 Neuropathic pain in children 
Most of the common neuropathic pain syndromes seen in adults are rare in pediatric 
population and some others are not even encountered. For example neuropathic pain from 
diabetic polineuropathy is never a significant concern in children. Pain as a consequence of 
stroke or radiculopathy or trigeminal neuralgia is tremendously rare in this period of life. 
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Children with plexus avulsion at birth or traumatic nerve injuries rarely develop neuropathic 
pain as most of the adult population does in a similar context. Also some conditions gain 
increasing recognition in this special group.The spectrum of etiologies that induce neuropathic 
pain in children are mostly  related to trauma, postsurgery, infectious myelitides, neuropathies 
(autoimmune, genetic), complex regional pain syndrome or phantom limb. Some of the rare 
neuropathic pain syndromes are exclusively encountered at this age: mitochondrial disorders, 
eritromelalgia, Fabry disease, lead intoxication (Walco et al. 2010). 
Favorable neuroplasticity  in younger patients might be the cause of a better recovery with 
lower incidence for neuropathic pain comparing to adults. Tools used in evaluation of 
adults with neuropathic pain could be extrapolated in children but aspects related to the 
developmental process should always taken into account as potentially modifiers of clinical 
expression. The assessment of pain and somatosensory examination is a challenging step in 
children. Appropriate instruments adapted for pediatric population are only developed for 
other types of pain: musculoskeletal, abdominal or headache (Craig & Korol, 2008). 
A controlled study conducted in a group of children aged 7 to 17 with unilateral CRPS using 
QST showed that patients displayed cold allodinia and a combination of dynamic 
mechanical allodinia and hyperalgezia to pinprick (Tan et al., 2008). 
A study that compared from medical records adult patients and children with CRPS and 
concluded that the skin temperature at onset was cooler among children, the lower 
extremity was involved more frequently and presence of sympathetic symptoms and 
abnormal neurological signs and symptoms were milder (Sethna et al., 2007). 
2.6.2 Neuropathic pain in the elderly 
Prevalence of neuropathic pain in the elderly population over 65 years of age is estimated 
around 9%(Bouhassira et al., 2007). 
Different etiologies may be responsible for neuropathic painful condition in older people 
but the most frequent are related to diabetes, shingles, radiculopathies and stroke. Most of 
the people in this group of age do not report pain adequately and usually think that pain is a 
normal part of the aging process (Pickering & Capriz, 2008). 
The most challenging points regarding the diagnostic approach in this age group are related 
to cognitive impairment and high incidence of affective disorders that will impact the way 
people report their pain or collaborate in answering to sometimes difficult questionnaires. 
Also comorbities are usually accumulated in this population and the chance of facing 
different types of pain (joints inflammation, visceral, neoplastic, related to treatments) is 
considerably high (Weiner et al., 2006). 
Instruments of pain assessment should be appropriate with the patient cognitive status and 
medical personnel should observe the patient’s behavior. Best instruments are the numeric 
and visual scale but also faces and behavioral scales (Pickering, 2005). 
2.6.3 Lessons learnt from randomized clinical trials (RCT’s) for neuropathic pain 
Most of the clinical trials were addressed to neuropathic pain associated with herpes zoster 
infection or diabetic neuropathy.  
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Regarding the outcome of different therapies, realistic expectations are defined by at least 30 
% of pain alleviation. Multiple dimensions of pain experience need to take into 
consideration sleep quality, depression and social impact. As a consequence, the efficacy of 
a certain therapy must be judged also from this perspective (Moulin et al., 2007). 
Evidences showed that different mechanisms and sensory profiles might be encountered in 
painful conditions with a similar etiology and conversely, one mechanism or sensory profile 
could be associated with different etiologies. For example cold hyperalgesia could be 
present in traumatic nerve injury but also in central post-stroke pain. Sympatheticaly 
maintained pain might characterize CRPS but also the acute pain in herpes zoster infection. 
As the time passes after the initial injury, multiple mechanisms get involved and become 
responsible for painful symptoms (Baron, 2006) 
Based on this observation, trials that used drugs combination as opioids and calcium 
channel ligands reported a better outcome with lower doses compared with single drug 
administration (Gilron et al., 2005, Hanna et al., 2008). Caution is recommended for 
combining tricyclic antidepressants and tramadol regarding the risk of  “serotonine 
syndrome”.  
The major classes of medication used for pharmacological treatment of neuropathic pain 
have different modes of action. Sometimes is difficult to understand how the specific mode 
of action of a certain drug interfere with the painful symptoms explained by a particular 
mechanism. On the other hand the success of a certain therapeutic intervention in 
alleviating pain is a clear opportunity to test a hypothesis regarding a certain association 
between mechanism and symptoms (Dworkin et al., 2003) 
Tricyclic antidepressants  act on monoamine reuptake, also block sodium channels and have 
anticholinergic effects as well. Apart from improving depression and sleep, this class of 
medication has unquestionable analgesic effect. Therefore is rated as level A indication for 
diabetic polineuropathy and postherpectic neuralgia and level B for central pain and chronic 
radiculopathy. 
Serotonine end norepinephrine selective reuptake inhibitors are only studied in diabetic 
polyneuropathies and rated level A for evidence of efficacy. No other relevant information 
is available regarding their action in other painful conditions. 
Calcium channel ligands lead to decrease of neurotransmitter release by acting on central 
terminals of primary nociceptive neurons were widely tested in the traditional models (DPN 
and PHN) but also in central pain syndromes and cancer related painful conditions. 
Similarly the agonists of opioid receptors demonstrated efficacy in several RCT’s conducted 
for peripheral as well as central neuropathic pain syndromes, cancer related and phantom 
pain (Dworkin et al., 2007). 
Topical application of lidocaine was demonstrated to be efficient in a patient population 
characterized by peripheral localized pain and allodynia as occurs in PHN. Its action is 
explained by a nonspecific blockage of sodium channels in the peripheral afferent fibers. 
Although patients displaying allodynia are considered the best candidates and represented 
the majority in clinical trials, patients without allodynia might have considerable benefit as 
well (Baron et al., 2009b). 
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Single dose capsaicin patch (8%) apart from excellent results in PHN trials (Backonja et al., 
2008), also proved it’s efficacy in treating pain related to HIV infection where other drugs 
had negative results (pregabaline, amytriptiline and topical lidocaine). Capsaicin patch acts 
as an agonist of TRPV1 receptor expressed on nociceptive nerve fibers in the skin (Simpson 
et al., 2008). 
The complex psychosocial aspects of neuropathic pain are sometimes addressed only by an 
integrated multidisciplinary approach including pharmacological and non-pharmacologic 
treatment strategies such as cognitive, behavioral, physical and occupational therapy 
(Oerlemans et al., 2000). For example an original concept such as graded motor imagery 
(mirror therapy) has been demonstrated to be efficient in reducing pain in patients suffering 
from CRPS or phantom pain (Moseley, 2006; Ramachandran & Altschuler, 2009). 
Interventional therapy is indicated for patients who failed to obtain sufficient relief with 
standard medication. RCT’s showed efficacy for invasive interventions in drug resistant 
patients with failed back surgery syndrome, postherpetic neuralgia or CRPS. Studies using 
functional magnetic resonance imaging (fMRI) in patients under spinal cord stimulation 
(SCS) found increased activation of the medial primary sensorimotor cortex, contralateral 
posterior insula, and the ipsilateral secondary somatosensory cortex (S2). Decreased 
activation was seen in the bilateral primary motor cortices and the ipsilateral primary 
somatosensory cortex (Stančák et al., 2009) 
3. Case discussions 
3.1 Case 1  
Male of 65 years old, known with myasthenia gravis under prednisone as 
immunosuppressive treatment developed herpes zoster infection in the left C3, C4, and 
C5 roots territory. He reported pain starting after 10 days from the vesicular rash onset 
and respecting the same distribution. During the first interview (3 months distance after 
vesicular rash remision) he described pain as a superficial burning, hot wire or shooting. 
Also he felt his skin like as a “cardboard”. His pain was coming and going in episodes 
that lasted seconds with complete pain free periods between these episodes. The intensity 
was rated 10 on the numeric rating scale and the daily activity and sleep were 
significantly disturbed. He had itching, pain attacks like electric shocks and very slight 
sensation of numbness in the painful area. The light touching, slight pressure and warm 
water elicited pain. The neurological exam showed an increased threshold to pinprick 
sensation, static and dynamic mechanical allodynia, heat allodynia and temporal 
summation in the painful area. On the skin, small areas of abnormal paleness have been 
noted as a consequence of rash healing (figure 1a, b). We used for assessment of pain, 
painDetect questionnaire and StEP. The total score obtained for painDetect was 21 and 
was considered positive for neuropathic pain.  
The paroxysmal pain, dysesthesia, raised pinprick threshold and threshold decreased for 
noxious heat stimuli pointed to a partial deafferentation of C and some of Aδ fibers and 
spontaneous activity in nociceptive afferents, probably related to abnormal expression of 
voltage-gated sodium channels and vanilloid receptor, TRPV1. The clinical picture also 
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suggests central sensitization process on spinal level by pre- and post-synaptic changes on 
second-order neuron induced by ongoing C input: temporal summation, mechanical 
dynamic and static allodynia. Analyzing the patient’s pain in this manner, it is easier to 
choose the potential optimal pharmacological agents. For this patient a selective sodium 
channel blocker, like carbamazepine or tricyclic antidepressive and μ-receptors agonists, 
opioids, are not suitable because of myasthenia gravis. A calcium-channel blocker ǂ2-δ 
ligand  was recommended with a rating of 8 (VAS) for the mean pain intensity per month. 
Further local application of capsaicin patch (8%) lowered the pain up to a rating of 5, which 
the patient considered acceptable in the long run. 
 
 
  
  Fig. 1. a)        Fig. 1. b) 
 
 
Fig. 1. 
3.2 Case 2 
Male of 47 years old was operated for lumbar disc herniation at L4-L5 manifested as acute 
severe low back pain associated with diffusely distributed and intermittent left leg pain in 
the groin and anterior thigh and a part of the lower leg. Postoperatively, a novel pain has 
occurred immediately after surgery. The patient was examined at 6 months interval from 
onset.This time the pain has been spontaneous, permanent, with a clear distribution in left 
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L5 root territory (left lateral lower leg and medial dorsum of foot toward the big toe). The 
pain’s intensity was rated 8/10 on the numeric rating scale, and the words sharp, stabbing, 
squeezing were used as descriptors. Also, the light touch on the dorsum of the foot 
determines pain. The low back pain still persists but only related to movements. No 
negative signs were found at the neurological exam.  
Compared to the pain before surgery, the actual pain has a specific topography for L5 root 
territory and it could be considered as a neuropathic one, even if the specific pain 
descriptors were missing. The pain is generated in the spinal root and not in the painful 
area. Mechanical dynamic allodynia described, is the expression of central sensitization. In 
this case, the central sensitization did not occurr secondary to ongoing C fibers input, 
instead of that, gating of Aǃ-fiber input, reduction of intraspinal inhibitory interneurons  
and changes in supraspinal descending modulation are the most probable mechanisms to 
explain the patient’s pain. Based on this judgment, topical pharmacological agents are 
useless. NMDA-receptor antagonists, μ-receptor agonists, GABA-B agonists or spinal cord 
stimulation are the reasonable options. 
3.3 Case 3 
Male of 45 years old complained about painful legs and weakness since he had an acute 
motor-sensory axonal neuropathy (AMSAN). The intensity of pain has been 9 from ten 
points on the numeric rating scale. The patient has spontaneous pain attacks superimposed 
on a milder but permanent pain largely distributed over the distal part of the limbs, but 
predominantly in the lower limbs where pain usually rise up to the knees. The words used 
to describe pain are: burning, electric shocks and stabbing. Also,at the interview he 
complained  that the pain could be provoked by light touch, slight pressure and heat and 
also reports an abnormal sensation such as prickling and numbness. The total score on 
painDetect questionnaire was 27, which is positive for neuropathic character of pain. 
Clinical examination revealed symmetrical weakness in all limbs, more in the legs, 
mechanical dynamic and static allodynia, heat allodynia, raised threshold to heat stimuli but 
the skin looked permanent cold and cyanotic skin and sometimes swollen and reddish when 
the pain was more intense. The clinical picture present many elements which suggest 
peripheral sensitization (dysesthesia, heat allodynia and raised threshold to heat) associated 
with abnormal recruiting of sympathetic nervous system. The central sensitization is 
pointed by mechanical dynamic and static allodynia. In this case because of the presence of 
sympathetic maintained pain, it seems logical to recommend tricyclic antidepressive drugs 
or sympathetic block, but it will not be sufficient and combination with other kind of drugs 
(calcium channel blocker, ǂ2-δ ligands, μ-receptor agonists, NMDA receptors antagonists) 
will be of very much help .  
4. Conclusion 
The effort of grouping patients according to sensory profiles will allow us to better 
understand the mechanisms involved in neuropathic pain development and persistence. 
Future trials will probably select specific sensory profiles across different etiologies and test 
treatment interventions from other perspectives. 
www.intechopen.com
 
Overview of Neuropathic Pain Diagnosis and Assessment – An Approach Based on Mechanisms 
 
23 
 
 
Fig. 2. Proposed algorithm for systematic approach for neuropathic pain assessment 
5. References  
[1] Amir R, Kocsis JD, Devor M.(2005). Multiple interacting sites of ectopic spike 
electrogenesis in primary sensory neurons. J Neurosci; 25: 2576–85. ISSN:0270-6474 
[2] Arning K, Baron R. (2009). Evaluation of symptom heterogeneity in neuropathic pain 
using assessments of sensory functions. Neurotherapeutics; 6: 738–48. ISSN: 1933-
7213 
[3] Attal N, Fermanian C, Fermanian J, Lanteri-Minet M, Alchaar H, Bouhassira D. (2008). 
Neuropathic pain: are there distinct subtypes depending on the aetiology or 
anatomical lesion? Pain.;138(2):343-353. ISSN: 0304-3959 
[4] Backonja M, Wallace MS, Blonsky ER. (2008). NGX-4010, a high concentration capsaicin 
patch, for the treatment of postherpetic neuralgia: a randomised, double-blind 
study. Lancet Neurol; 7: 1106–12. ISSN: 1474-4422 
[5] Baron R. (2006). Mechanism of Disease: neuropathic pain-a clinical perspective. Nat. Clin. 
Pract. Neurol; 2: 95–106. ISSN: 1745-834X 
[6] Baron R, Tolle TR, Gockel U, Brosz M, Freynhagen R.( 2009). A crosssectional cohort 
survey in 2100 patients with painful diabetic neuropathy and postherpetic 
neuralgia: differences in demographic data and sensory symptoms, Pain; 146: 34–
40. ISSN: 0304-3959 
[7] Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I, Serpell M. (2009) 5% lidocaine 
medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic 
PAIN
     ACUTE 
< 6-12 weeks 
 CHRONIC 
>6-12 weeks 
          QUESTIONNAIRE 
self-report, for ex., painDetect, NPSI 
 NOCICEPTIVE 
         PAIN 
   uncertain score for 
NEUROPATHIC PAIN
       certain score for 
NEUROPATHIC PAIN
CLINICAL EXAM 
StEP 
Abnormal non-painful  
         sensations 
Paresthesia 
Dysesthesia 
Spontaneous activity  
in LT Aβ afferents 
Spontaneous activity 
in C/Aδ affents 
   Positive 
phenomena 
Spontaneous 
        pain
Ongoing
Paroxystic
Evoked  
   pain
Allodynia/ 
hyperalgesia
Temporal summation 
Aftersensations
           Primary 
allodynia/hyperalgesia 
        Secondary 
allodynia/hyperalgesia 
Central sensitization Peripheral sensitization 
  Negative 
phenomena 
Sensory  
  deficit 
Pallesthezia  
(an)hypoesthesia 
   -Aβ afferents- 
(an)hypoalgesia 
cold (an)hypoesthesia 
    -Aδ afferents- 
warm (an)hypoesthesia 
       - C afferents- 
 Vegetative 
dysfunctions 
Skin changes 
Vasomotor disturbances 
Sudomotor disturbances 
www.intechopen.com
 
Neuropathic Pain 
 
24
polyneuropathy: an open-label, non- inferiority two-stage RCT study. Curr Med Res 
Opin; 25: 1663–76. ISSN: 0300-7995   
[8] Baron R., Binder A., Wasner G.(2010).Neuropathic pain: diagnosis, pathophysiological 
mechanism and treatment. Lancet Neurology. 9:807-19. ISSN: 1474-4422 
[9] Bennett MI, Attal N, Backonja MM. (2007). Using screening tools to identify neuropathic 
pain. Pain. 127: 199–203. ISSN: 0304-3959 
[10] Bennett MI (2001) The LANSS Pain Scale: The Leeds Assessment of Neuropathic 
Symptoms and Signs. Pain 92: 147–157. ISSN: 0304-3959   
[11] Black JA, Nikolajsen L, Kroner K, Jensen TS, Waxman SG. (2008). Multiple sodium 
channel isoforms and mitogen-activated protein kinases are present in painful 
human neuromas, Ann Neurol; 64: 644–53. ISSN: 0364-5134 
[12] Boucsein C, Kettenmann H, Nolte C. (2000). Electrophysiological properties of 
microglial cells in normal and pathologic rat brain slices. Eur J Neurosci, 12:2049-
2058. ISSN: 1460-9568 
[13] Bouhassira D., Attal N., Fermanian J., Alchaar H., Gautron M., Masquelier E., Rostaing S., 
Lanteri-Minet M., Collin E., Grisare J., Boureau F. (2004). Development and validation 
of the Neuropathic Pain Symptom Inventory. Pain 108 248–257; ISSN: 0304-3959 
[14] Bouhassira D, Attal N, Alchaar H, Boureau F, Bruxelle J, Cunin G, et al. (2005). 
Comparison of pain syndromes associated with nervous or somatic lesions and 
development of a new neuropathic pain diagnostic questionnaire (DN4). 
Pain;114:29–36. ISSN: 0304-3959 
[15] Bouhassira D, Lantéri-Minet M, Attal N, Laurent B, Touboul C. (2008) Prevalence of 
chronic pain with neuropathic characteristics in the general population. Pain 
136(3):380-7. ISSN: 0304-3959 
[16] Bromm B, Treede RD. (1984). Nerve fibre discharges, cerebral potentials and sensations 
induced by CO2 laser stimulation, Hum Neurobiol, 3:33–40; ISSN: 0721-9075 
[17] Caterina MJ, Julius D., (2001) The vanilloid receptor: a molecular gateway to the pain 
pathway, Annu Rev Neurosci; 24: 487–517. ISSN: 0147-006X 
[18] Cruccu G.,. Anand P, Attal N., Garcia-Larrea L., Haanpää M., Jørum E.,. Serra J, and 
Jensen T. S. (2004) EFNS guidelines on neuropathic pain assessment, European 
Journal of Neurology, 11: 153–162; ISSN: 1351-5101 
[19] Cruccu G., Truini A. (2009). Tools for Assessing Neuropathic Pain. PLoS Med., doi:  
10.1371/journal.pmed.1000045;   
[20] Cruccu G., Sommera C., Anand P., N. Attal, Baron R., Garcia-Larrea L., Haanpa M.,. Jensen 
T. S, Serra J. and. Treede R.D., (2010) EFNS guidelines on neuropathic pain assessment: 
revised 2009. European Journal of Neurology; 17(8):1010-18. ISSN: 1351-5101 
[21] Craig KD, Korol CT. (2008). Developmental issues in understanding, assessing, and 
managing pediatric pain. In: Pain in Children: A Practical Guide for Primary Care. 
Walco GA, Goldschneider KR, eds. Totowa, NJ 07512: Humana Press; 9-20. USA, 
ISBN:978-1-934115-31-2  
[22] Devigili G., Tugnoli V., Penza P., Camozzi F., Lombardi R., Melli G., Broglio L., Granieri 
E., Lauria G.,(2003). The diagnostic criteria for small fibre neuropathy: from 
symptoms to neuropathology, Brain; 131:1912-1925. ISSN: 0006-8950 
www.intechopen.com
 
Overview of Neuropathic Pain Diagnosis and Assessment – An Approach Based on Mechanisms 
 
25 
[23] Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennett GJ, Bushnell 
MC, Farrar JT, Galer BS, Haythornthwaite JA, Hewitt DJ, Loeser JD, Max MB, 
Saltarelli M, Schmader KE, Stein C, Thompson D, Turk DC, Wallace MS, Watkins 
LR, Weinstein SM. (2003).Advances in Neuropathic Pain: diagnosis, mechanism 
and treatment recommendations. Arch Neurol.;60(11):1524-1534. ISSN: 1013-3119 
[24] Finnerup N., Troels J.S. , (2006). Mechanisms of Disease: mechanism-based classification of 
neuropathic pain—a critical analysis, Nature Clinical Practice;2(2)107-15. ISSN: 1745-834X 
[25] Fischer MJ, Reeh PW.(2007). Sensitization to heat through G-proteincoupled receptor 
pathways in the isolated sciatic mouse nerve, Eur J Neurosci; 25: 3570–75. ISSN: 
1351-5101 
[26] Freynhagen R, Baron R, Gockel U, Tolle T., (2006). PainDetect: a new screeing 
questionnaire to detect neuropathic components in patients with back pain, Curr 
Med Res Opin;22: 1911–20. ISSN: 0300-7995 
[27] Galer BS, Jensen MP. (1997). Development and preliminary validation of a pain 
measure specific to neuropathic pain: the Neuropathic Pain Scale., 
Neurology;48:332–8. ISSN:0028-3878 
[28] Garcia-Larrea L., Godinho F., (2007). Diagnostic Role of Laser-evoked Potentials in 
Central Neuropathic Pain, European neurological disease.II 
[29] Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, 
or their combination for neuropathic pain. (2005). N Engl J Med; 352: 1324–34.  
[30] Gilron I.,  Peter C., Watson N.,  Cahill M.,  Moulin E. (2006).Neuropathic Pain: a 
practical guide for the clinician, CMAJ. ISSN: 0820-3946. 
[31] Gosselin RD, Suter MR, Ji RR, Decosterd I (2010): Glial Cells and Chronic Pain. 
Neuroscientist. 16(5):519-31. ISSN:1073-8584. 
[32] Gray P. (2008). Acute neuropathic pain: diagnosis and treatment, Current Opinion in 
Anaesthesiology.21(5):590-595. ISSN: 0952—7907. 
[33] Haanpaa M., Attal N., Backonja M., Baron R., Bouhassira D., Crrucu G., Hansson P., 
Haithomthwaite JA, Iannetti GD, Jensen TS,, Kaupila T., Nurmikko TJ, Rice AS, 
RowbothamM., Serra J., Sommer C., Smith BH, Treede RD.(2011). NeuPSIG 
guidelines on neuropathic pain assessment. Pain. 152(1):14-27.ISSN: 0304-3959  
[34] Hains BC, Saab CY, Klein JP, Craner MJ, Waxman SG. (2004).Altered sodium channel 
expression in second-order spinal sensory neurons contributes to pain after 
peripheral nerve injury., J Neurosci; 24: 4832–39. ISSN: 0270-6474 
[35] Hanna M, O’Brien C, Wilson MC. (2008). Prolonged-release oxycodone enhances the 
effects of existing gabapentin therapy in painful diabetic neuropathy patients. Eur J 
Pain; 12: 804–13. ISSN: 1090-3801 
[36] Hayes C, Browne S., Burstal R., (2002). Neuropathic pain in the acute pain service: a 
prospective survey, Acute Pain; 4;2; 45-8. ISSN: 1366-0071 
[37] Jensen T. S., Towards a mechanism-based approach to the treatment of neuropathic 
pain. In: Neuropathic Pain: Bench to Bedside - International Congress and 
Symposium Series 259-2005;  
[38] Jensen T. S., Baron R., (2003).Translation of symptoms and signs into mechanism in 
neuropathic pain,; Pain;102(1-2):1-8. ISSN: 0304-3959 
www.intechopen.com
 
Neuropathic Pain 
 
26
[39] Ji RR, Suter MR. (2007). p38 MAPK, microglial signaling, and neuropathic pain. Mol 
Pain, 3:33. ISSN: 1744-8069.  
[40] Kaki AM, El-Yaski AZ, Youseif E., (2005). Identifying neuropathic pain among patients 
with chronic low-back pain: use of the Leeds Assessment of Neuropathic 
Symptoms and Signs pain scale, Reg Anesth Pain Med; 30:422–8. ISSN: 1098-7339 
[41] Karanikolas M., Aretha D., Tsolakis, I. et al., Optimized perioperative analgesia reduces 
chronic phantom limb pain intensity, prevalence, and frequency: a prospective, 
randomized, clinical trial, Anesthesiology, vol. 114, no. 5, pp. 1144–1154. ISSN: 003-3022 
[42] Krause SJ, Backonja MM. (2003). Development of a Neuropathic Pain Questionnaire, 
Clin J Pain; 19:306–14. ISSN: 0749-8047. 
[43] Kennedy WR., Opportunities afforded by the study of unmyelinated nerves in skin and 
other organs.(2004). Muscle Nerve; 29:756–67. ISSN: 0148-639X 
[44] Kennedy WR,Wendelschafer-Crabb G, Polydefkis M, et al., Pathology and quantitation 
of cutaneous innervation. (2005) In: Peripheral neuropathy. Dyck PJ, Thomas PK, 
editors. 4th edition. Philadelphia (PA): Elsevier Saunders;. p. 869–95; USA  
[45] Lai J, Hunter JC, Porreca F., (2003). The role of voltage-gated sodium channels in 
neuropathic pain, Curr Opin Neurobiol; 13: 291–97. ISSN: 0959-4388. 
[46] Low VA, Sandroni P, Fealey RD, et al. (2006). Detection of small-fiber neuropathy by 
sudomotor testing, Muscle Nerve; 34:57–61. ISSN: 0148-639X.  
[47] Ma W, Zhang Y, Bantel C, Eisenach JC. (2005). Medium and large injured dorsal root 
ganglion cells increase TRPV-1, accompanied by increased alpha2C-adrenoceptor co-
expression and functional inhibition by clonidine. Pain; 113: 386–94. ISSN: 0304-3959. 
[48] Maier C, Baron R, Toelle T, et al. (2010). Quantitative Sensory Testing in the German 
Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 
1236 patients with different neuropathic pain syndromes. Pain; 150(3):439-450. 
ISSN: 0304-3959. 
[49] McGrath PJ, Walco GA, Turk DC, et al. PedIMMPACT. (2008). Core outcome domains 
and measures for pediatric acute and chronic/recurrent pain clinical trials: 
PedIMMPACT recommendations. J Pain. 9(9):771-783.  
[50] Moore KA, Kohno T, Karchewski LA, Scholz J, Baba H, Woolf CJ. (2002). Partial 
peripheral nerve injury promotes a selective loss of GABAergic inhibition in the 
superficial dorsal horn of the spinal cord. J Neurosci; 22: 6724–31. ISSN: 0270-6474. 
[51] Moseley GL. (2006). Graded motor imagery for pathologic pain: a randomized 
controlled trial. Neurology; 67: 2129–34. ISSN: 0028-3878  
[52] Moulin DE, Clark AJ, Gilron I, et al. (2007). Pharmacological management of chronic 
neuropathic pain-consensus statement and guidelines from the Canadian Pain 
Society. Pain Res Manag; 12: 13–21. ISSN: 1203-6765. 
[53] Novak V, Freimer ML, Kissel JT, et al., (2001). Autonomic impairment in painful 
neuropathy, Neurology;56:861–8. ISSN: 0028-3878 
[54] Oerlemans HM, Oostendorp RA, de Boo T, van der Laan L, Severens JL, Goris JA. 
(2000). Adjuvant physical therapy versus occupational therapy in patients with 
reflex sympathetic dystrophy/ complex regional pain syndrome type I. Arch Phys 
Med Rehabil; 81: 49–56. ISSN  
www.intechopen.com
 
Overview of Neuropathic Pain Diagnosis and Assessment – An Approach Based on Mechanisms 
 
27 
[55] Potter J, Higginson IJ, Scadding JW, Quigley CW. (2003). Identifying neuropathic pain 
in patients with head and neck cancer: use of the Leeds Assessment of Neuropathic 
Symptoms and Signs Scale, J R Soc Med.;96:379–83. ISSN: 0141-0768. 
[56] Portenoy R.,(2006). Development and testing of a neuropathic pain screening 
questionnaire: ID Pain. Curr Med Res Opin;22:1555–65. ISSN: 0300-7995. 
[57] Pickering G, Capriz F. (2008). Neuropathic pain in the elderly. Psychol NeuroPsychiatr 
Vieil. 6 (2) : 107-14. ISSN: 2212-4926. 
[58] Pickering G. (2005). Age differences in clinical pain states. In :.Pain in older persons. 
Gibson SJ, Weiner DK, eds: IASP Press, : 67-85.8. Seattle, USA  
[59] Ramachandran VS, Altschuler EL.( 2009). The use of visual feedback, in particular mirror 
visual feedback, in restoring brain function. Brain; 132: 1693–710. ISSN: 0006-8950 
[60] Rolke R, Baron R, Maier C, et al.,(2006). Quantitative sensory testing in the German 
Research Network on Neuropathic Pain (DFNS): standardized protocol and 
reference values, Pain; 123: 231–43. ISSN: 0304-3959 
[61] Scholz J, Mannion RJ, Hord DE, Griffin RS, Rawal B, et al., (2009) A novel tool for the 
assessment of pain: Validation in low back pain. PLoS Med 6(4):e1000047, 
doi:10.1371/journal.pmed.1000047; 
[62] Scholz J, Broom DC, Youn DH, et al. (2005). Blocking caspase activity prevents 
transsynaptic neuronal apoptosis and the loss of inhibition in lamina II of the 
dorsal horn after peripheral  nerve injury. J Neurosci; 25: 7317–23  
[63] Sethna NF, Meier PM, Zurakowski D, Berde CB. (2007). Cutaneous sensory 
abnormalities in children and adolescents with complex regional pain syndromes. 
Pain.;131(1-2):153-161. ISSN: 0304-3959 
[64] Serra J, Sola R, Quiles C, et al.(2009). C- nociceptors sensitized to cold in a patient with 
small-fiber neuropathy and cold allodynia. Pain; 147: 46–53. ISSN: 0304-3959 
[65] Simpson DM, Brown S, Tobias J. (2008). Controlled trial of high concentration capsaicin 
patch for treatment of painful HIV neuropathy. Neurology; 70: 2305–13.ISSN: 0028-3878 
[66] Siqueira SR, Alves B, Malpartida HM, Teixeira MJ, Siqueira JT. (2009). Abnormal 
expression of voltage-gated sodium channels Nav1.7, Nav1.3 and Nav1.8 in 
trigeminal neuralgia, Neuroscience; 164: 573–77.  
[67] Steven H. Horowitz, (2007). The Diagnostic Workup of Patients with Neuropathic Pain, 
Anesthesiology Clin. 25 699–708 
[68] Subedi B., Grossberg G.T. (2011). Phantom Limb Pain: Mechanisms and Treatment 
Approaches. Pain Research and Treatment,  
[69] Stančák A., Kozák J, Vrba I, Tintěra J, Vrána J , Poláček H, Stančák M. (2008). Functional 
magnetic resonance imaging of cerebral activation during spinal cord stimulation 
in failed back surgery syndrome patients. European Journal of Pain; 12:137-48  
[70] Tan EC, Zijlstra B, Essink ML, Goris RJ, Severijnen RS. (2008).Complex regional pain 
syndrome type I in children. Acta Paediatr.;97(7):875-879.  
[71] Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, et al. (2008) Neuropathic 
pain: Redefinition and a grading system for clinical and research purposes. 
Neurology 70: 1630–1635. ISSN: 0028-3878 
www.intechopen.com
 
Neuropathic Pain 
 
28
[72] Walco G.A, Dworkin R, Elliot J. Krane,  LeBel, A.A. and Treede RD. (2010). Neuropathic 
Pain in Children: Special Considerations. Mayo Clin Proc.;85(3)(suppl):S33-S41. 
ISSN: 0025-6196 
[73] Weiner DK, Rudy TE, Morrow L, Slaboda J, Lieber S. (2006).The relationship between pain, 
neuropsychological performance, and physical function in community-dwelling older 
adults with chronic low back pain. Pain Med  ; 7 : 60-70.24. ISSN: 1526-2375 
[74] Woolf CJ. In: Hyperalgesia and Allodynia. (1992). Willis W, ed. New York, NY: Raven 
Press;221-243.  
[75] Woolf CJ, Bennett GJ, Doherty M, et al. (1998).Towards a mechanism-based 
classification of pain? Pain; 77: 227–29.147: 46–53. ISSN: 0304-3959   
[76] Wu G, Ringkamp M, Murinson BB, et al. (2002). Degeneration of myelinated eff erent 
fibers induces spontaneous activity in uninjured C-fiber afferents. J Neurosci; 22: 
7746–53. 42. ISSN: 0270-6474  
[77] Ultenius C, Linderoth B, Meyerson BA, Wallin J. (2006). Spinal, NMDA receptor 
phosphorylation correlates with the presence of neuropathic signs following 
peripheral nerve injury in the rat. Neurosci Lett; 399: 85–90. ISSN: 0304-3940 
[78] Zhuo M., Gongxiong W., Long-Jun W.( 2011). Neuronal and glial mechanisms of 
neuropathic pain. Molecular Brain,4:31. ISSN: 1756-6606 
www.intechopen.com
Neuropathic Pain
Edited by Dr. Cyprian Chukwunonye Udeagha
ISBN 978-953-51-0452-0
Hard cover, 140 pages
Publisher InTech
Published online 28, March, 2012
Published in print edition March, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Neuropathic pain is known to be pain with nerve involvement. The intensity of which depends on the severity,
pain threshold and the ability of suffers to cope. Neuropathic pain may need mono-therapy or combination of
therapies to be resolved. Neuropathic pain may not resolve completely, therefore patient's compliance and
understanding is essential in its management. Awareness and patient's education on targets may be of help
during therapies for neuropathic pain. All chapters treated introduction, characteristics, diagnosis and
randomized interventions to certain management of neuropathic pain. We acknowledge all those involve in the
making of this book.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Ioana Mindruta, Ana-Maria Cobzaru and Ovidiu Alexandru Bajenaru (2012). Overview of Neuropathic Pain
Diagnosis and Assessment – An Approach Based on Mechanisms, Neuropathic Pain, Dr. Cyprian
Chukwunonye Udeagha (Ed.), ISBN: 978-953-51-0452-0, InTech, Available from:
http://www.intechopen.com/books/neuropathic-pain/overview-of-neuropathic-pain-diagnosis-and-assessment-
an-approach-based-on-mechanisms
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
